Frequency Therapeutics is pioneering a new category in regenerative medicine that aims to restore human function by developing therapeutics that activate a person’s innate regenerative potential within the body through the activation of progenitor cells. The Company’s lead preclinical program is designed to activate oligodendrocyte precursor cells with the goal of driving remyelination and potential functional recovery for individuals living with multiple sclerosis.
Annual Report and Proxy Statement
Sep 21, 2023 7:30 PM EDT
Data Provided by Refinitiv. Minimum 15 minutes delayed.